Home 5 Lab Compliance Advisor 5 CLIA-lca 5 FDA and CMS Address LDT Regulation Before Energy and Commerce Committee

FDA and CMS Address LDT Regulation Before Energy and Commerce Committee

by | Dec 1, 2015

Last week, the U.S. House of Representatives Energy and Commerce Committee heard testimony about oversight of laboratory developed tests (LDTs) from representatives of the U.S. Food and Drug Administration (FDA) and Centers for Medicare and Medicaid Services (CMS). The opportunity to speak at the hearing, titled "Examining the Regulation of Diagnostic Tests and Laboratory Operations," […]

Last week, the U.S. House of Representatives Energy and Commerce Committee heard testimony about oversight of laboratory developed tests (LDTs) from representatives of the U.S. Food and Drug Administration (FDA) and Centers for Medicare and Medicaid Services (CMS). The opportunity to speak at the hearing, titled "Examining the Regulation of Diagnostic Tests and Laboratory Operations," […]

This content is Exclusive to Lab Compliance Advisor Subscribers

Subscribe or Log in for Exclusive Access.